The Impact of Obstructive Sleep Apnea on Metabolic and Inflammatory Markers in Consecutive Patients with Metabolic Syndrome

被引:203
作者
Drager, Luciano F. [1 ,2 ]
Lopes, Heno F. [1 ]
Maki-Nunes, Cristiane [1 ]
Trombetta, Ivani C. [1 ]
Toschi-Dias, Edgar [1 ]
Alves, Maria Janieire N. N. [1 ]
Fraga, Raffael F. [1 ]
Jun, Jonathan C. [2 ]
Negrao, Carlos E. [1 ]
Krieger, Eduardo M. [1 ]
Polotsky, Vsevolod Y. [2 ]
Lorenzi-Filho, Geraldo [1 ]
机构
[1] Univ Sao Paulo, Sch Med, Heart Inst InCor, Sao Paulo, Brazil
[2] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA
来源
PLOS ONE | 2010年 / 5卷 / 08期
基金
美国国家卫生研究院;
关键词
C-REACTIVE PROTEIN; URIC-ACID LEVELS; INTERMITTENT HYPOXIA; INSULIN-RESISTANCE; DAYTIME SLEEPINESS; RISK; POPULATION; MORTALITY; OBESITY; ATHEROSCLEROSIS;
D O I
10.1371/journal.pone.0012065
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: Obstructive Sleep Apnea (OSA) is tightly linked to some components of Metabolic Syndrome (MetS). However, most of the evidence evaluated individual components of the MetS or patients with a diagnosis of OSA that were referred for sleep studies due to sleep complaints. Therefore, it is not clear whether OSA exacerbates the metabolic abnormalities in a representative sample of patients with MetS. Methodology/Principal Findings: We studied 152 consecutive patients (age 48 +/- 9 years, body mass index 32.3 +/- 3.4 Kg/m(2)) newly diagnosed with MetS (Adult Treatment Panel III). All participants underwent standard polysomnography irrespective of sleep complaints, and laboratory measurements (glucose, lipid profile, uric acid and C-reactive protein). The prevalence of OSA (apnea-hypopnea index >= 15 events per hour of sleep) was 60.5%. Patients with OSA exhibited significantly higher levels of blood pressure, glucose, triglycerides, cholesterol, LDL, cholesterol/HDL ratio, triglycerides/HDL ratio, uric acid and C-reactive protein than patients without OSA. OSA was independently associated with 2 MetS criteria: triglycerides: OR: 3.26 (1.47-7.21) and glucose: OR: 2.31 (1.12-4.80). OSA was also independently associated with increased cholesterol/HDL ratio: OR: 2.38 (1.08-5.24), uric acid: OR: 4.19 (1.70-10.35) and C-reactive protein: OR: 6.10 (2.64-14.11). Indices of sleep apnea severity, apnea-hypopnea index and minimum oxygen saturation, were independently associated with increased levels of triglycerides, glucose as well as cholesterol/HDL ratio, uric acid and C-reactive protein. Excessive daytime sleepiness had no effect on the metabolic and inflammatory parameters. Conclusions/Significance: Unrecognized OSA is common in consecutive patients with MetS. OSA may contribute to metabolic dysregulation and systemic inflammation in patients with MetS, regardless of symptoms of daytime sleepiness.
引用
收藏
页数:8
相关论文
共 43 条
[1]  
Grundy Scott M, 2005, Crit Pathw Cardiol, V4, P198
[2]   Impact of Body Mass Index and the Metabolic Syndrome on the Risk of Cardiovascular Disease and Death in Middle-Aged Men [J].
Arnlov, Johan ;
Ingelsson, Erik ;
Sundstrom, Johan ;
Lind, Lars .
CIRCULATION, 2010, 121 (02) :230-U88
[3]   Uric acid is a risk factor for myocardial infarction and stroke - The Rotterdam Study [J].
Bos, Michiel J. ;
Koudstaal, Peter J. ;
Hofman, Albert ;
Witteman, Jacqueline C. M. ;
Breteler, Monique M. B. .
STROKE, 2006, 37 (06) :1503-1507
[4]   Influence of metabolic syndrome and general obesity on the risk of ischemic stroke [J].
Chen, HJ ;
Bai, CH ;
Yeh, WT ;
Chiu, HC ;
Pan, WH .
STROKE, 2006, 37 (04) :1060-1064
[5]   Associations Between Obstructive Sleep Apnea, Metabolic Syndrome, and Sleep Duration, As Measured With an Actigraph, in an Urban Male Working Population in Japan [J].
Chin, Kazuo ;
Oga, Toru ;
Takahashi, Ken-ichi ;
Takegami, Misa ;
Nakayama-Ashida, Yukiyo ;
Wakamura, Tomoko ;
Sumi, Kensuke ;
Nakamura, Takaya ;
Horita, Sachiko ;
Oka, Yasunori ;
Minami, Itsunari ;
Fukuhara, Shunichi ;
Kadotani, Hiroshi .
SLEEP, 2010, 33 (01) :89-95
[6]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[7]   Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome [J].
Coughlin, SR ;
Mawdsley, L ;
Mugarza, JA ;
Calverley, PMA ;
Wilding, JPH .
EUROPEAN HEART JOURNAL, 2004, 25 (09) :735-741
[8]   Early signs of atherosclerosis in obstructive sleep apnea [J].
Drager, LF ;
Bortolotto, LA ;
Lorenzi, MC ;
Figueiredo, AC ;
Krieger, EM ;
Lorenzi, G .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (05) :613-618
[9]  
Drager LF., 2009, J Cardiometab Syndr, V4, P89, DOI [10.1111/j.1559-4572.2008.00046.x, DOI 10.1111/J.1559-4572.2008.00046.X]
[10]   The incremental role of obstructive sleep apnoea on markers of atherosclerosis in patients with metabolic syndrome [J].
Drager, Luciano F. ;
Bortolotto, Luiz A. ;
Maki-Nunes, Cristiane ;
Trombetta, Ivani C. ;
Alves, Maria Janieire N. N. ;
Fraga, Raffael F. ;
Negrao, Carlos E. ;
Krieger, Eduardo M. ;
Lorenzi-Filho, Geraldo .
ATHEROSCLEROSIS, 2010, 208 (02) :490-495